ACUTE LEUKEMIA IN REMISSION

Clinical trials for ACUTE LEUKEMIA IN REMISSION explained in plain language.

Never miss a new study

Get alerted when new ACUTE LEUKEMIA IN REMISSION trials appear

Sign up with your email to follow new studies for ACUTE LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Weight loss drug could protect brain function in chronic illness

Knowledge-focused Recruiting now

This study is testing whether a weight loss medication called liraglutide (Saxenda) affects brain health markers in people with multiple sclerosis, long COVID, or leukemia in remission who also have obesity and cognitive problems. Researchers will measure changes in a protein cal…

Matched conditions: ACUTE LEUKEMIA IN REMISSION

Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused

Last updated Mar 20, 2026 14:48 UTC

ACUTE LEUKEMIA IN REMISSION

Get alerted when new ACUTE LEUKEMIA IN REMISSION trials appear

Weight loss drug could protect brain function in chronic illness